SEARCH

SEARCH BY CITATION

References

  • Appay, V., Zaunders, J.J., Papagno, L., Sutton, J., Jaramillo, A., Waters, A., Easterbrook, P., Grey, P., Smith, D., McMichael, A.J., Cooper, D.A., Rowland-Jones, S.L. & Kelleher, A.D. (2002) Characterization of CD4(+) CTLs ex vivo. Journal of Immunology, 168, 59545958.
  • Aruga, E., Tanigawa, K., Aruga, A., Arai, H., Smith, J.W. II, Nickoloff, B.J., Nabel, G.J. & Chang, A.E. (2000) CD95-mediated tumor recognition by CD4+ effector cells in a murine mammary model. Journal of Immunotherapy, 23, 225234.
  • Baum, T.P., Pasqual, N., Thuderoz, F., Hierle, V., Chaume, D., Lefranc, M.P., Jouvin-Marche, E., Marche, P.N. & Demongeot, J. (2004) IMGT/GeneInfo: enhancing V(D)J recombination database accessibility. Nucleic Acids Research, 32 (Database issue), D51D54.
  • Bendandi, M., Gocke, C.D., Kobrin, C.B., Benko, F.A., Sternas, L.A., Pennington, R., Watson, T.M., Reynolds, C.W., Gause, B.L., Duffey, P.L., Jaffe, E.S., Creekmore, S.P., Longo, D.L. & Kwak, L.W. (1999) Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma. Nature Medicine, 5, 11711177.
  • Bonnefoix, T. & Sotto, J.J. (1994) The standard chi 2 test used in limiting dilution assays is insufficient for estimating the goodness-of-fit to the single-hit Poisson model. Journal of Immunological Methods, 167, 2133.
  • Bonnefoix, T., Bonnefoix, P., Callanan, M., Verdiel, P. & Sotto, J.J. (2001) Graphical representation of a generalized linear model-based statistical test estimating the fit of the single-hit Poisson model to limiting dilution assays. Journal of Immunology, 167, 57255730.
  • Bonnefoix, T., Mi, J.Q., Perron, P., Callanan, M., Semoun, C., Favre, M., Renversez, J.C., Sotto, M.F., Leroux, D. & Sotto, J.J. (2002) Terminal plasmocytoid differentiation of malignant B cells induced by autotumor-reactive CD4(+) T cells in one case of splenic marginal zone B-cell lymphoma. Blood, 99, 388391.
  • Bouhdoud, L., Villain, P., Merzouki, A., Arella, M. & Couture, C. (2000) T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide. Journal of Virology, 74, 21212130.
  • Claret, E., Praloran, V., Zheng, X., Bonnefoix, T., Sotto, M.F., Renversez, J.C., Piccinni, M.P., Berrada, L. & Sotto, J.J. (1992) Accumulation of T-cell clones producing high levels of both granulocyte-macrophage and macrophage colony-stimulating factors (CSF-1) in lymph nodes involved by Hodgkin's disease. Leukemia, 6, 820827.
  • Dudley, M.E., Wunderlich, J.R., Robbins, P.F., Yang, J.C., Hwu, P., Schwartzentruber, D.J., Topalian, S.L., Sherry, R., Restifo, N.P., Hubicki, A.M., Robinson, M.R., Raffeld, M., Duray, P., Seipp, C.A., Rogers-Freezer, L., Morton, K.E., Mavroukakis, S.A., White, D.E. & Rosenberg, S.A. (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science, 298, 850854.
  • Dudley, M.E., Wunderlich, J.R., Yang, J.C., Sherry, R.M., Topalian, S.L., Restifo, N.P., Royal, R.E., Kammula, U., White, D.E., Mavroukakis, S.A., Rogers, L.J., Gracia, G.J., Jones, S.A., Mangiameli, D.P., Pelletier, M.M., Gea-Banacloche, J., Robinson, M.R., Berman, D.M., Filie, A.C., Abati, A. & Rosenberg, S.A. (2005) Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. Journal of Clinical Oncology, 23, 23462357.
  • Eray, M., Postila, V., Eeva, J., Ripatti, A., Karjalainen-Lindsberg, M.-L., Knuutila, S., Andersson, L.C. & Pelkonen, J. (2003) Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre B cells. Scandinavian Journal of Immunology, 57, 545555.
  • Esser, M.T., Haverstick, D.M., Fuller, C.L., Gullo, C.A. & Braciale, V.L. (1998) Ca2+ signaling modulates cytolytic T lymphocyte effector functions. Journal of Experimental Medicine, 187, 10571067.
  • Fehervari, Z. & Sakaguchi, S. (2004) CD4+ Tregs and immune control. Journal of Clinical Investigation, 114, 12091217.
  • Flynn, S. & Stockinger, B. (2003) Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation. Blood, 101, 44724478.
  • Gilboa, E. (1999) The makings of a tumor rejection antigen. Immunity, 11, 263270.
  • Gilboa, E. (2004) The promise of cancer vaccines. Nature Reviews Cancer, 4, 401411.
  • Godfrey, D.I., Hammond, K.J., Poulton, L.D., Smyth, M.J. & Baxter, A.G. (2000) NKT cells: facts, functions and fallacies. Immunology Today, 21, 573583.
  • Godfrey, D.I., MacDonald, H.R., Kronenberg, M., Smyth, M.J. & Van Kaer, L. (2004) NKT cells: what's in a name? Nature Reviews Immunology, 4, 231237.
  • Houghton, A.N., Gold, J.S. & Blachere, N.E. (2001) Immunity against cancer: lessons learned from melanoma. Current Opinion in Immunology, 13, 134140.
  • Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D. & Levitsky, H. (1998) The central role of CD4(+) T cells in the antitumor immune response. Journal of Experimental Medicine, 188, 23572368.
  • Ju, S.T., Cui, H., Panka, D.J., Ettinger, R. & Marshak-Rothstein, A. (1994) Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. Proceedings of the National Academy of Sciences of the United States of America, 91, 41854189.
  • Kataoka, T., Shinohara, N., Takayama, H., Takaku, K., Kondo, S., Yonehara, S. & Nagai, K. (1996) Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. Journal of Immunology, 156, 36783686.
  • Khong, H.T. & Restifo, N.P. (2002) Natural selection of tumor variants in the generation of ‘‘tumor escape’’ phenotypes. Nature Immunology, 3, 9991005.
  • Lajmanovich, A., Irisarri, M., Molens, J.P., Pasquier, M.A., Sotto, J.J., Bensa, J.C., Leroux, D. & Plumas, J. (2004) Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells. British Journal of Haematology, 124, 746753.
  • Lefranc, M.P. (2003) IMGT, the international ImMunoGeneTics database. Nucleic Acids Research, 31, 307310.
  • Li, J.H., Rosen, D., Ronen, D., Behrens, C.K., Krammer, P.H., Clark, W.R. & Berke, G. (1998) The regulation of CD95 ligand expression and function in CTL. Journal of Immunology, 161, 39433949.
  • Lundin, K.U., Hofgaard, P.O., Omholt, H., Munthe, L.A., Corthay, A. & Bogen, B. (2003) Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies. Blood, 102, 605612.
  • Martin, I., Bonnefoix, T., Roucard, C., Perron, P., Lajmanovich, A., Moine, A., Leroux, D., Sotto, J.J. & Garban, F. (1999) Role of autologous CD4+ T cell clones in human B non-Hodgkin's lymphoma: aborted activation and G1 blockade induced by cell-cell contact. European Journal of Immunology, 29, 31883195.
  • Marusic-Galesic, S., Udaka, K. & Walden, P. (1993) Increased number of cytotoxic T cells within CD4+8- T cells in beta 2-microglobulin, major histocompatibility complex class I-deficient mice. European Journal of Immunology, 23, 31153119.
  • Marzo, A.L., Kinnear, B.F., Lake, R.A., Frelinger, J.J., Collins, E.J., Robinson, B.W. & Scott, B. (2000) Tumor-specific CD4+ T cells have a major ‘‘post-licensing’’ role in CTL mediated anti-tumor immunity. Journal of Immunology, 165, 60476055.
  • Mattes, J., Hulett, M., Xie, W., Hogan, S., Rothenberg, M.E., Foster, P. & Parish, C. (2003) Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. Journal of Experimental Medicine, 197, 387393.
  • Miskovsky, E.P., Liu, A.Y., Pavlat, W., Viveen, R., Stanhope, P.E., Finzi, D., Fox, III, W.M., Hruban, R.H., Podack, E.R. & Siliciano, R.F. (1994) Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines. Journal of Immunology, 153, 27872799.
  • Mumberg, D., Monach, P.A., Wanderling, S., Philip, M., Toledano, A.Y., Schreiber, R.D. & Schreiber, H. (1999) CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. Proceedings of the National Academy of Sciences of the United States of America, 96, 86338638.
  • Nagata, K., Tanaka, K., Ogawa, K., Kemmotsu, K., Imai, T., Yoshie, O., Abe, H., Tada, K., Nakamura, M., Sugamura, K. & Takano, S. (1999) Selective expression of a novel surface molecule by human Th2 cells in vivo. Journal of Immunology, 162, 12781286.
  • Nikiforow, S., Bottomly, K., Miller, G. & Munz, C. (2003) Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein–Barr virus-induced B-cell proliferation. Journal of Virology, 77, 1208812104.
  • Ochoa, M.T., Stenger, S., Sieling, P.A., Thoma-Uszynski, S., Sabet, S., Cho, S., Krensky, A.M., Rollinghoff, M., Nunes Sarno, E., Burdick, A.E., Rea, T.H. & Modlin, R.L. (2001) T-cell release of granulysin contributes to host defense in leprosy. Nature Medicine, 7, 174179.
  • Ohminami, H., Yasukawa, M., Kaneko, S., Yakushijin, Y., Abe, Y., Kasahara, Y., Ishida, Y. & Fujita, S. (1999) Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide. Blood, 93, 925935.
  • Ossendorp, F., Toes, R.E., Offringa, R., Van Der Burg, S.H. & Melief, C.J. (2000) Importance of CD4(+) T helper cell responses in tumor immunity. Immunology Letters, 74, 7579.
  • Pardoll, D.M. & Topalian, S.L. (1998) The role of CD4+ T cell responses in antitumor immunity. Current Opinion in Immunology, 10, 588594.
  • Pasqual, N., Gallagher, M., Aude-Garcia, C., Loiodice, M., Thuderoz, F., Demongeot, J., Ceredig, R., Marche, P.N. & Jouvin-Marche, E. (2002) Quantitative and qualitative changes in V-J alpha rearrangements during mouse thymocytes differentiation: implication for a limited T cell receptor alpha chain repertoire. Journal of Experimental Medicine, 196, 11631173.
  • Pelham, H.R. (1991) Multiple targets for brefeldin A. Cell, 67, 449451.
  • Plumas, J., Chaperot, L., Jacob, M.C., Molens, J.P., Giroux, C., Sotto, J.J. & Bensa, J.C. (1995) Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7–1) and CD86 (B7–2) in stimulation by tumor cells. European Journal of Immunology, 25, 33323341.
  • Plumas, J., Jacob, M.C., Chaperot, L., Molens, J.P., Sotto, J.J. & Bensa, J.C. (1998) Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. Blood, 91, 28752885.
  • Puisieux, I., Even, J., Pannetier, C., Jotereau, F., Favrot, M. & Kourilsky, P. (1994) Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. Journal of Immunology, 153, 28072818.
  • Qin, Z. & Blankenstein, T. (2000) CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity, 12, 677686.
  • Rathmell, J.C., Cooke, M.P., Ho, W.Y., Grein, J., Townsend, S.E., Davis, M.M. & Goodnow, C.C. (1995) CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature, 376, 181184.
  • Sallusto, F., Mackay, C.R. & Lanzavecchia, A. (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annual Review of Immunology, 18, 593620.
  • Schmaltz, C., Alpdogan, O., Horndasch, K.J., Muriglan, S.J., Kappel, B.J., Teshima, T., Ferrara, J.L., Burakoff, S.J. & Van Den Brink, M.R. (2001) Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood, 97, 28862895.
  • Schultz, E.S., Schuler-Thurner, B., Stroobant, V., Jenne, L., Berger, T.G., Thielemanns, K., Van Der Bruggen, P. & Schuler, G. (2004) Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy. Journal of Immunology, 172, 13041310.
  • Shi, I., Bonnefoix, T., Heuze-Le Vacon, F., Jacob, M.C., Leroux, D., Gressin, R., Sotto, M.F., Chaffanjon, P., Bensa, J.C. & Sotto, J.J. (1995) Autotumour reactive T-cell clones among tumour-infiltrating T lymphocytes in B-cell non-Hodgkin's lymphomas. British Journal of Haematology, 90, 837843.
  • Sun, Q., Burton, R.L. & Lucas, K.G. (2002) Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein–Barr virus-specific T-cell cultures. Blood, 99, 33023309.
  • Theodorou, I., Bigorgne, C., Delfau, M.H., Lahet, C., Cochet, G., Vidaud, M., Raphael, M., Gaulard, P. & Farcet, J.P. (1996) VJ rearrangements of the TCR gamma locus in peripheral T-cell lymphomas: analysis by polymerase chain reaction and denaturing gradient gel electrophoresis. Journal of Pathology, 178, 303310.
  • Umetsu, D.T., Esserman, L., Donlon, T.A., DeKruyff, R.H. & Levy, R. (1990) Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. Journal of Immunology, 144, 25502557.
  • Vigan, I., Jouvin-Marche, E., Leroy, V., Pernollet, M., Tongiani-Dashan, S., Borel, E., Delachanal, E., Colomb, M., Zarski, J.P. & Marche, P.N. (2003) T lymphocytes infiltrating the liver during chronic hepatitis C infection express a broad range of T-cell receptor beta chain diversity. Journal of Hepatology, 38, 651659.
  • Wang, R.F. (2001) The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. Trends in Immunology, 22, 269276.
  • Wang, S., Boonman, Z.F., Li, H.C., He, Y., Jager, M.J., Toes, R.E. & Niederkorn, J.Y. (2003) Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye. Journal of Immunology, 171, 27892796.
  • Williams, N.S. & Engelhard, V.H. (1996) Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. Journal of Immunology, 156, 153159.
  • Yanai, F., Ishii, E., Kojima, K., Hasegawa, A., Azuma, T., Hirose, S., Suga, N., Mitsudome, A., Zaitsu, M., Ishida, Y., Shirakata, Y., Sayama, K., Hashimoto, K. & Yasukawa, M. (2003) Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells. Journal of Immunology, 170, 22052213.
  • Yang, Z.Z., Novak, A.J., Stenson, M.J., Witzig, T.E. & Ansell, S.M. (2006) Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood, 107, 36393646.
  • Yasukawa, M., Yakushijin, Y., Hasegawa, H., Miyake, M., Hitsumoto, Y., Kimura, S., Takeuchi, N. & Fujita, S. (1993) Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytotoxic T-cell clones. Blood, 81, 15271534.
  • Yee, C., Thompson, J.A., Byrd, D., Riddell, S.R., Roche, P., Celis, E. & Greenberg, P.D. (2002) Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proceedings of the National Academy of Sciences of the United States of America, 99, 1616816173.